Q: What is Restasis used for?

Restasis is used to treat keratoconjunctivitis sicca .

Q: How does Restasis work?

Mechanism of Action Restasis contains cyclosporine, which belongs to a class of medications known as immunomodulators. In many cases of chronic dry eye, also known as keratoconjunctivitis sicca, the eyes do not produce enough tears because of ongoing inflammation in the tear glands and on the surface of the eye. While the exact way the medication works is not fully understood, it is believed to function by: Lowering inflammation: The active ingredient helps suppress the immune response that causes swelling and irritation in the tear-producing tissues. Restoring tear production: By reducing this inflammation, the medication allows the tear glands to function more effectively, increasing the eyes' natural ability to stay moist. It is important to note that Restasis is intended for patients whose tear production is suppressed specifically due to ocular inflammation. It may not increase tear production in patients who are already using topical anti-inflammatory drugs or those who have tear duct plugs.

Q: What are the active ingredients in Restasis?

The active ingredient in Restasis is cyclosporine .

Q: What are the side effects of Restasis?

Common side effects of Restasis may include: Eye burning Eye redness Blurred vision Always consult with a healthcare professional about potential side effects.

Q: What drug class is Restasis?

Restasis belongs to the calcineurin inhibitor immunosuppressant drug class.

Q: What is the dosage of Restasis and how do I take it?

How to Use Restasis Restasis is typically used twice a day, approximately 12 hours apart. Before applying the drops, wash your hands thoroughly. If you are using the single-use vials, invert the vial several times until the liquid appears uniform and opaque white. If using the multi-dose bottle, follow the specific instructions provided for priming and dispensing the medication. To apply the drops: Tilt your head back and pull down the lower eyelid to create a small pocket. Hold the dropper or vial above the eye without letting the tip touch your eye, eyelashes, or any other surface. Squeeze the liquid into the pocket created by the lower lid. Close your eye for a minute or two and apply gentle pressure to the inside corner of the eye to keep the liquid from draining into the tear duct. If you use single-use vials, discard the container immediately after use, even if there is medicine left inside. For multi-dose bottles, ensure the cap is replaced tightly after each use. Special Instructions If you wear contact lenses, they should be removed before using Restasis. You may reinsert them 15 minutes after applying the drops. If you use other eye medications, such as artificial tears, wait at least 15 minutes between using Restasis and the other product. Missed Dose If you miss a dose, apply it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular routine. Do not use extra medicine to make up for a missed dose.

Q: Is Restasis safe during pregnancy and breastfeeding?

Pregnancy There are no adequate and well-controlled studies of Restasis in pregnant women. Clinical data on its use during pregnancy are limited. However, because the medication is applied topically to the eye, systemic absorption into the bloodstream is very low and often undetectable. This suggests that the risk of birth defects or miscarriage is likely minimal. If you are pregnant or planning to become pregnant, discuss the potential risks and benefits of using this medication with your healthcare provider. Breastfeeding It is unknown if cyclosporine passes into human breast milk after being used as an eye drop. While the systemic absorption of Restasis is minimal, healthcare providers typically advise caution for nursing mothers. Decisions regarding the use of Restasis while breastfeeding should be made in consultation with a doctor to weigh the benefits of treatment against any potential risks to the infant.

Q: What forms and strengths does Restasis come in?

Dosage Forms Restasis (cyclosporine ophthalmic emulsion) is a topical medication for use in the eyes. It is available in two primary packaging options: Single-use vials: These are individual, preservative-free containers. Each vial is intended for a single application to one or both eyes. Once opened, the vial should be used immediately and any remaining liquid must be discarded. Multi-dose Preservative-Free (MDPF) bottle: This is a multi-dose bottle designed with a specialized tip that prevents contamination, allowing the emulsion to remain sterile without the use of preservatives. Available Strengths Restasis is supplied in a concentration of 0.05%.

Q: What is the FDA approval status of Restasis?

FDA Approval and Indications The U.S. Food and Drug Administration (FDA) approved Restasis (cyclosporine ophthalmic emulsion) 0.05% in 2002. It is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca, commonly known as chronic dry eye. The medication is not expected to increase tear production in patients who are currently using topical anti-inflammatory drugs or those who have punctal plugs. Generic Availability In February 2022, the FDA approved the first generic version of Restasis (cyclosporine ophthalmic emulsion 0.05% single-use vials). Generic versions are required to meet the same standards for quality, strength, and purity as the brand-name product. Regulatory Oversight Restasis is available by prescription only. There are currently no boxed warnings or Risk Evaluation and Mitigation Strategy (REMS) programs required for this medication. The FDA continues to monitor the safety and efficacy of the drug through standard post-marketing surveillance.

Question 1

What is Restasis?

Accepted Answer

Restasis contains the active ingredient cyclosporine, which functions as an immunomodulator. It is designed to help the eyes produce more natural tears by addressing certain types of inflammation that can limit tear volume.

This medication works to support the eye's natural moisture-producing processes.

Question 2

What is Restasis used for?

Accepted Answer

Restasis is used to treat keratoconjunctivitis sicca.

Question 3

How does Restasis work?

Accepted Answer

Mechanism of Action

Restasis contains cyclosporine, which belongs to a class of medications known as immunomodulators. In many cases of chronic dry eye, also known as keratoconjunctivitis sicca, the eyes do not produce enough tears because of ongoing inflammation in the tear glands and on the surface of the eye.

While the exact way the medication works is not fully understood, it is believed to function by:

Lowering inflammation: The active ingredient helps suppress the immune response that causes swelling and irritation in the tear-producing tissues.
Restoring tear production: By reducing this inflammation, the medication allows the tear glands to function more effectively, increasing the eyes' natural ability to stay moist.

It is important to note that Restasis is intended for patients whose tear production is suppressed specifically due to ocular inflammation. It may not increase tear production in patients who are already using topical anti-inflammatory drugs or those who have tear duct plugs.

Question 4

What are the active ingredients in Restasis?

Accepted Answer

The active ingredient in Restasis is cyclosporine.

Question 5

What are the side effects of Restasis?

Accepted Answer

Common side effects of Restasis may include:

Eye burning
Eye redness
Blurred vision

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Restasis?

Accepted Answer

Restasis belongs to the calcineurin inhibitor immunosuppressant drug class.

Question 7

What is the dosage of Restasis and how do I take it?

Accepted Answer

How to Use Restasis

Restasis is typically used twice a day, approximately 12 hours apart. Before applying the drops, wash your hands thoroughly. If you are using the single-use vials, invert the vial several times until the liquid appears uniform and opaque white. If using the multi-dose bottle, follow the specific instructions provided for priming and dispensing the medication.

To apply the drops:

Tilt your head back and pull down the lower eyelid to create a small pocket.
Hold the dropper or vial above the eye without letting the tip touch your eye, eyelashes, or any other surface.
Squeeze the liquid into the pocket created by the lower lid.
Close your eye for a minute or two and apply gentle pressure to the inside corner of the eye to keep the liquid from draining into the tear duct.

If you use single-use vials, discard the container immediately after use, even if there is medicine left inside. For multi-dose bottles, ensure the cap is replaced tightly after each use.

Special Instructions

If you wear contact lenses, they should be removed before using Restasis. You may reinsert them 15 minutes after applying the drops. If you use other eye medications, such as artificial tears, wait at least 15 minutes between using Restasis and the other product.

Missed Dose

If you miss a dose, apply it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular routine. Do not use extra medicine to make up for a missed dose.

Question 8

Is Restasis safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate and well-controlled studies of Restasis in pregnant women. Clinical data on its use during pregnancy are limited. However, because the medication is applied topically to the eye, systemic absorption into the bloodstream is very low and often undetectable. This suggests that the risk of birth defects or miscarriage is likely minimal.

If you are pregnant or planning to become pregnant, discuss the potential risks and benefits of using this medication with your healthcare provider.

Breastfeeding

It is unknown if cyclosporine passes into human breast milk after being used as an eye drop. While the systemic absorption of Restasis is minimal, healthcare providers typically advise caution for nursing mothers. Decisions regarding the use of Restasis while breastfeeding should be made in consultation with a doctor to weigh the benefits of treatment against any potential risks to the infant.

Question 9

What forms and strengths does Restasis come in?

Accepted Answer

Dosage Forms

Restasis (cyclosporine ophthalmic emulsion) is a topical medication for use in the eyes. It is available in two primary packaging options:

Single-use vials: These are individual, preservative-free containers. Each vial is intended for a single application to one or both eyes. Once opened, the vial should be used immediately and any remaining liquid must be discarded.
Multi-dose Preservative-Free (MDPF) bottle: This is a multi-dose bottle designed with a specialized tip that prevents contamination, allowing the emulsion to remain sterile without the use of preservatives.

Available Strengths

Restasis is supplied in a concentration of 0.05%.

Question 10

What is the FDA approval status of Restasis?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved Restasis (cyclosporine ophthalmic emulsion) 0.05% in 2002. It is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca, commonly known as chronic dry eye.

The medication is not expected to increase tear production in patients who are currently using topical anti-inflammatory drugs or those who have punctal plugs.

Generic Availability

In February 2022, the FDA approved the first generic version of Restasis (cyclosporine ophthalmic emulsion 0.05% single-use vials). Generic versions are required to meet the same standards for quality, strength, and purity as the brand-name product.

Regulatory Oversight

Restasis is available by prescription only. There are currently no boxed warnings or Risk Evaluation and Mitigation Strategy (REMS) programs required for this medication. The FDA continues to monitor the safety and efficacy of the drug through standard post-marketing surveillance.

Question 11

What should I know about Restasis and cost?

Accepted Answer

Generic Availability

Generic versions of Restasis (cyclosporine 0.05% ophthalmic emulsion) are available. Choosing a generic medication is often a primary way to reduce out-of-pocket expenses, as generics are typically priced lower than brand-name drugs.

Insurance and Pharmacy Factors

Most insurance plans and Medicare Part D cover cyclosporine ophthalmic emulsion, though the specific copay or coinsurance amount depends on the plan's formulary. Additionally, prices can vary between different retail pharmacies and mail-order services.

Financial Assistance

Patients may be able to lower their costs through several programs:

Manufacturer Savings Cards: The manufacturer may offer savings cards or coupons for eligible patients with commercial insurance to help reduce out-of-pocket costs.
Patient Assistance Programs: Some programs provide medications at a lower cost or for free to individuals who meet specific income requirements and do not have insurance coverage.

Restasis

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Restasis

Hospitals.net Disclosure